Symbols / BNBX $0.81 +9.18%
BNBX Chart
About
BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. BNB Plus Corp. was formerly known as Applied DNA Sciences, Inc. and changed its name to BNB Plus Corp. in November 2025. The company was founded in 1983 and is based in Stony Brook, New York.
Fundamentals
Scroll to Statements| Sector | Financial Services | Industry | Asset Management | Market Cap | 4.42M |
| Enterprise Value | 1.64M | Income | -70.16M | Sales | 1.83M |
| Book/sh | 3.95 | Cash/sh | 0.45 | Dividend Yield | — |
| Payout | 0.00% | Employees | 26 | IPO | — |
| P/E | 0.00 | Forward P/E | — | PEG | — |
| P/S | 2.41 | P/B | 0.21 | P/C | — |
| EV/EBITDA | -0.06 | EV/Sales | 0.90 | Quick Ratio | 1.36 |
| Current Ratio | 2.32 | Debt/Eq | 0.27 | LT Debt/Eq | — |
| EPS (ttm) | 282.39 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -35.00% | Earnings | 2026-05-15 | ROA | -97.97% |
| ROE | -199.14% | ROIC | — | Gross Margin | 29.91% |
| Oper. Margin | -32.49% | Profit Margin | 0.00% | Shs Outstand | 5.45M |
| Shs Float | 5.35M | Short Float | 0.38% | Short Ratio | 0.24 |
| Short Interest | — | 52W High | 35.85 | 52W Low | 0.61 |
| Beta | 0.69 | Avg Volume | 137.40K | Volume | 90.52K |
| Target Price | — | Recom | None | Prev Close | $0.74 |
| Price | $0.81 | Change | 9.18% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.81
Latest analyst target
3. DCF / Fair value
$-57.51
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.81
Low
—
High
—
Mean
—
- BNB Plus holds over $10.7M in BNB tokens, above its market cap - Stock Titan ue, 24 Feb 2026 08
- symbol__ Stock Quote Price and Forecast - CNN Wed, 08 Oct 2025 14
- BNBX | BNB Plus Corp. Common Stock Data, Price & News - Quiver Quantitative Sun, 15 Mar 2026 14
- BNBX Stock Price, Quote & Chart | BNB PLUS CORP (NASDAQ:BNBX) - ChartMill Wed, 11 Mar 2026 07
- BNB Plus lands EU patent on enzyme to speed mRNA drug output - Stock Titan Wed, 18 Mar 2026 12
- Inside the Crypto Stock Frenzy: How a $58 Million BNB Bet Sent Applied DNA Into Chaos - Yahoo Finance hu, 16 Oct 2025 07
- BNBX Stock Price and Chart — NASDAQ:BNBX - TradingView ue, 07 Oct 2025 14
- Applied DNA stock soars after closing $27 million PIPE financing - Investing.com Wed, 22 Oct 2025 07
- What is the current Price Target and Forecast for BNB Plus Corp. (BNBX) - Zacks Investment Research Fri, 21 Nov 2025 21
- BNBX | BNB Plus Corp. Common Institutional Ownership - Quiver Quantitative Sun, 15 Mar 2026 14
- Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX’ Reflecting Digital Asset Treasury Strategy - Business Wire Mon, 06 Oct 2025 07
- Applied DNA Sciences Rebrands to BNB Plus Corp. - The Globe and Mail ue, 18 Nov 2025 08
- BNBX Stock Surge: Time to Act? - StocksToTrade Wed, 22 Oct 2025 07
- Applied DNA (BNBX) Stock Surges on $58M Binance BNB Crypto Bet; New Ticker Takes Effect - TechStock² Wed, 22 Oct 2025 07
- BNBX Stock Price, News & Analysis - Stock Titan Wed, 22 Oct 2025 12
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 22511 | — | — | Stock Award(Grant) at price 0.00 per share. | CATELL ROBERT B | Director | — | 2025-10-17 00:00:00 | D |
| 1 | 22511 | — | — | Stock Award(Grant) at price 0.00 per share. | SHAMASH YACOV A | Director | — | 2025-10-17 00:00:00 | D |
| 2 | 18691 | — | — | Stock Award(Grant) at price 0.00 per share. | MURRAH JUDITH | Director | — | 2025-10-17 00:00:00 | D |
| 3 | 22511 | — | — | Stock Award(Grant) at price 0.00 per share. | CECCOLI JOSEPH D | Director | — | 2025-10-17 00:00:00 | D |
| 4 | 18691 | — | — | Stock Award(Grant) at price 0.00 per share. | JANTZEN BETH M | Chief Financial Officer | — | 2025-10-17 00:00:00 | D |
| 5 | 22511 | — | — | Stock Award(Grant) at price 0.00 per share. | SCHMALZ ELIZABETH M. | Director | — | 2025-10-17 00:00:00 | D |
| 6 | 18691 | — | — | Stock Award(Grant) at price 0.00 per share. | SHORROCK CLAY | Chief Executive Officer | — | 2025-10-17 00:00:00 | D |
Financials
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 13.74K | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.04 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -15.98M | -20.00M | -10.45M | -18.42M |
| TotalUnusualItems | 319.63K | 6.77M | 854.40K | 5.74M |
| TotalUnusualItemsExcludingGoodwill | 319.63K | 6.77M | 854.40K | 5.74M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -14.77M | -6.69M | -9.95M | -8.27M |
| ReconciledDepreciation | 384.17K | 432.60K | 1.36M | 1.29M |
| ReconciledCostOfRevenue | 1.30M | 1.14M | 7.83M | 13.12M |
| EBITDA | -15.66M | -13.24M | -9.59M | -12.68M |
| EBIT | -16.05M | -13.67M | -10.95M | -13.97M |
| NetInterestIncome | 192.91K | 120.48K | 75.33K | 7.20K |
| InterestIncome | 192.91K | 120.48K | 75.33K | 7.20K |
| NormalizedIncome | -15.07M | -13.46M | -10.80M | -14.01M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -15.16M | -6.99M | -9.95M | -8.27M |
| TotalExpenses | 18.18M | 15.78M | 24.32M | 32.14M |
| TotalOperatingIncomeAsReported | -16.05M | -13.67M | -10.95M | -13.97M |
| DilutedAverageShares | 517.67K | 5.29K | 910.00 | 860.00 |
| BasicAverageShares | 517.67K | 5.29K | 910.00 | 860.00 |
| DilutedEPS | -134.23 | -1.37K | -10.93K | -9.74K |
| BasicEPS | -134.23 | -1.37K | -10.93K | -9.74K |
| DilutedNIAvailtoComStockholders | -69.49M | -7.23M | -9.95M | -8.38M |
| NetIncomeCommonStockholders | -69.49M | -7.23M | -9.95M | -8.38M |
| OtherunderPreferredStockDividend | 54.33M | 233.09K | 0.00 | 110.11K |
| NetIncome | -15.16M | -6.99M | -9.95M | -8.27M |
| MinorityInterests | 188.52K | 95.78K | 75.86K | 2.17K |
| NetIncomeIncludingNoncontrollingInterests | -15.35M | -7.09M | -10.02M | -8.27M |
| NetIncomeDiscontinuousOperations | -392.73K | -300.50K | ||
| NetIncomeContinuousOperations | -14.96M | -6.79M | -10.02M | -8.27M |
| TaxProvision | -684.12K | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -15.64M | -6.79M | -10.02M | -8.27M |
| OtherIncomeExpense | 213.05K | 6.76M | 855.04K | 5.69M |
| OtherNonOperatingIncomeExpenses | -106.58K | -8.88K | 642.00 | -47.30K |
| SpecialIncomeCharges | 0.00 | 0.00 | -1.76M | |
| OtherSpecialCharges | 934.72K | |||
| ImpairmentOfCapitalAssets | 0.00 | 821.74K | ||
| RestructuringAndMergernAcquisition | 0.00 | 1.67M | 0.00 | |
| GainOnSaleOfSecurity | 319.63K | 6.77M | 854.40K | 5.74M |
| NetNonOperatingInterestIncomeExpense | 192.91K | 120.48K | 75.33K | 7.20K |
| TotalOtherFinanceCost | -13.68K | |||
| InterestIncomeNonOperating | 192.91K | 120.48K | 75.33K | 7.20K |
| OperatingIncome | -16.05M | -13.67M | -10.95M | -13.97M |
| OperatingExpense | 16.89M | 14.64M | 16.49M | 19.02M |
| DepreciationAmortizationDepletionIncomeStatement | 844.44K | |||
| DepreciationAndAmortizationInIncomeStatement | 844.44K | |||
| ResearchAndDevelopment | 6.02M | 3.59M | 3.74M | 3.93M |
| SellingGeneralAndAdministration | 10.87M | 11.05M | 12.75M | 15.10M |
| GrossProfit | 838.91K | 974.84K | 5.53M | 5.05M |
| CostOfRevenue | 1.30M | 1.14M | 7.83M | 13.12M |
| TotalRevenue | 2.14M | 2.11M | 13.37M | 18.17M |
| OperatingRevenue | 2.14M | 2.11M | 13.37M | 18.17M |
| Line Item | 2023-09-30 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 1.66M | 13.75K | 910.00 | 860.00 |
| ShareIssued | 1.66M | 13.75K | 910.00 | 860.00 |
| TotalDebt | 193.25K | 739.16K | 1.24M | 0.00 |
| TangibleBookValue | 2.30M | 6.44M | 2.25M | 12.91M |
| InvestedCapital | 2.30M | 9.14M | 4.95M | 12.91M |
| WorkingCapital | -225.49K | 5.65M | 5.28M | 15.76M |
| NetTangibleAssets | 2.30M | 6.44M | 2.25M | 12.91M |
| CapitalLeaseObligations | 193.25K | 739.16K | 1.24M | 0.00 |
| CommonStockEquity | 2.30M | 9.14M | 4.95M | 12.91M |
| TotalCapitalization | 2.30M | 9.14M | 4.95M | 12.91M |
| TotalEquityGrossMinorityInterest | 1.94M | 8.97M | 4.87M | 12.91M |
| MinorityInterest | -363.05K | -174.53K | -78.75K | -2.89K |
| StockholdersEquity | 2.30M | 9.14M | 4.95M | 12.91M |
| RetainedEarnings | -379.16M | -309.67M | -302.45M | -292.50M |
| AdditionalPaidInCapital | 381.46M | 318.82M | 307.40M | 305.40M |
| CapitalStock | 1.66K | 14.00 | 683.00 | 12.91K |
| CommonStock | 1.66K | 14.00 | 683.00 | 12.91K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 2.50M | 3.82M | 8.78M | 9.36M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 31.84K | 1.42M | 5.93M | 5.17M |
| DerivativeProductLiabilities | 370.00 | 320.00K | 4.29M | 5.14M |
| NonCurrentAccruedExpenses | 31.47K | 31.47K | 31.47K | 31.47K |
| NonCurrentDeferredLiabilities | 0.00 | 878.12K | 878.12K | 0.00 |
| NonCurrentDeferredRevenue | 0.00 | 194.00K | 194.00K | 0.00 |
| NonCurrentDeferredTaxesLiabilities | 0.00 | 684.12K | 684.12K | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 0.00 | 193.25K | 739.16K | 0.00 |
| LongTermCapitalLeaseObligation | 0.00 | 193.25K | 739.16K | 0.00 |
| CurrentLiabilities | 2.46M | 2.40M | 2.85M | 4.19M |
| OtherCurrentLiabilities | 56.06K | |||
| CurrentDeferredLiabilities | 12.29K | 58.78K | 76.44K | 563.56K |
| CurrentDeferredRevenue | 12.29K | 58.78K | 76.44K | 563.56K |
| CurrentDebtAndCapitalLeaseObligation | 193.25K | 545.91K | 498.60K | |
| CurrentCapitalLeaseObligation | 193.25K | 545.91K | 498.60K | 0.00 |
| PayablesAndAccruedExpenses | 2.26M | 1.74M | 2.27M | 3.62M |
| CurrentAccruedExpenses | 285.32K | 118.42K | 59.99K | 418.99K |
| Payables | 1.97M | 1.62M | 2.21M | 3.20M |
| OtherPayable | 1.13M | 480.76K | 1.14M | 1.46M |
| AccountsPayable | 844.78K | 1.14M | 1.07M | 1.74M |
| TotalAssets | 4.44M | 12.79M | 13.65M | 22.27M |
| TotalNonCurrentAssets | 2.20M | 4.74M | 5.53M | 2.32M |
| OtherNonCurrentAssets | 750.00K | 844.34K | 750.00K | |
| NonCurrentPrepaidAssets | 2.98K | 0.00 | 0.00 | 99.00K |
| NonCurrentDeferredAssets | 1.01M | 0.00 | ||
| GoodwillAndOtherIntangibleAssets | 0.00 | 2.70M | 2.70M | 0.00 |
| OtherIntangibleAssets | 2.70M | 2.70M | ||
| NetPPE | 435.97K | 1.20M | 2.08M | 2.22M |
| AccumulatedDepreciation | -3.29M | -2.92M | -3.41M | -2.07M |
| GrossPPE | 3.72M | 4.12M | 5.49M | 4.29M |
| Leases | 124.83K | 124.83K | 124.83K | 124.83K |
| OtherProperties | 3.60M | 4.00M | 5.31M | 4.06M |
| MachineryFurnitureEquipment | 56.47K | 56.47K | 108.36K | 108.36K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 2.24M | 8.05M | 8.13M | 19.94M |
| OtherCurrentAssets | 242.15K | 756.18K | 389.24K | 1.06M |
| AssetsHeldForSaleCurrent | 6.97K | 678.15K | ||
| PrepaidAssets | 1.06M | 568.88K | ||
| Inventory | 84.10K | 432.73K | 330.03K | 602.24K |
| FinishedGoods | 18.60K | 136.33K | 98.09K | 74.48K |
| WorkInProcess | 0.00 | 221.25K | 19.86K | 55.82K |
| RawMaterials | 65.50K | 75.14K | 212.08K | 471.95K |
| Receivables | 237.40K | 328.25K | 255.50K | 3.07M |
| AccountsReceivable | 237.40K | 328.25K | 255.50K | 3.07M |
| AllowanceForDoubtfulAccountsReceivable | 0.00 | -75.00K | -75.00K | -330.85K |
| GrossAccountsReceivable | 237.40K | 403.25K | 330.50K | 3.40M |
| CashCashEquivalentsAndShortTermInvestments | 1.67M | 5.85M | 7.15M | 15.22M |
| CashAndCashEquivalents | 1.67M | 5.85M | 7.15M | 15.22M |
| CashEquivalents | 15.22M | 6.55M |
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| FreeCashFlow | -12.83M | -14.12M | -6.30M | -9.47M |
| RepaymentOfDebt | 0.00 | -1.67M | ||
| IssuanceOfDebt | 0.00 | |||
| IssuanceOfCapitalStock | 5.71M | 13.40M | 0.00 | 14.43M |
| CapitalExpenditure | -313.12K | -407.90K | -78.45K | -489.55K |
| InterestPaidSupplementalData | 0.00 | 0.00 | 0.00 | 0.00 |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 2.42M | 7.18M | 7.90M | 15.22M |
| BeginningCashPosition | 7.18M | 7.90M | 15.22M | 6.55M |
| ChangesInCash | -4.76M | -720.71K | -7.31M | 8.66M |
| FinancingCashFlow | 8.05M | 13.40M | 0.00 | 18.13M |
| CashFlowFromContinuingFinancingActivities | 8.05M | 13.40M | 0.00 | 18.13M |
| NetOtherFinancingCharges | -166.34K | |||
| ProceedsFromStockOptionExercised | 2.51M | 394.00 | 0.00 | 3.70M |
| NetCommonStockIssuance | 5.71M | 13.40M | 0.00 | 14.43M |
| CommonStockIssuance | 5.71M | 13.40M | 0.00 | 14.43M |
| NetIssuancePaymentsOfDebt | 0.00 | -1.67M | ||
| NetLongTermDebtIssuance | 0.00 | -1.67M | ||
| LongTermDebtPayments | 0.00 | -1.67M | ||
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | -292.12K | -407.90K | -1.10M | -489.55K |
| CashFromDiscontinuedInvestingActivities | 21.00K | 0.00 | ||
| CashFlowFromContinuingInvestingActivities | -313.12K | -407.90K | -1.10M | -489.55K |
| NetBusinessPurchaseAndSale | 0.00 | -1.06M | 0.00 | |
| PurchaseOfBusiness | 0.00 | -1.06M | 0.00 | |
| NetIntangiblesPurchaseAndSale | 0.00 | |||
| PurchaseOfIntangibles | 0.00 | |||
| NetPPEPurchaseAndSale | -313.12K | -407.90K | -33.45K | -489.55K |
| SaleOfPPE | 0.00 | 45.00K | 0.00 | |
| PurchaseOfPPE | -313.12K | -407.90K | -78.45K | -489.55K |
| OperatingCashFlow | -12.52M | -13.71M | -6.22M | -8.98M |
| CashFromDiscontinuedOperatingActivities | -276.04K | -121.18K | ||
| CashFlowFromContinuingOperatingActivities | -12.24M | -13.59M | -6.22M | -8.98M |
| ChangeInWorkingCapital | 380.85K | -1.06M | 2.45M | 954.57K |
| ChangeInOtherWorkingCapital | 43.50K | -17.65K | -293.12K | 282.56K |
| ChangeInPayablesAndAccruedExpense | -516.72K | -412.17K | -1.35M | 930.50K |
| ChangeInPrepaidAssets | 511.06K | -391.69K | 767.81K | -493.22K |
| ChangeInInventory | 348.62K | -118.59K | 272.22K | 767.69K |
| ChangeInReceivables | -5.61K | -115.29K | 3.05M | -532.96K |
| ChangesInAccountReceivables | -5.61K | -115.29K | 3.05M | -532.96K |
| OtherNonCashItems | 650.31K | 1.67M | ||
| StockBasedCompensation | 102.02K | 572.29K | 1.03M | 2.52M |
| ProvisionandWriteOffofAssets | 0.00 | -239.04K | 269.45K | 28.63K |
| AssetImpairmentCharge | 2.85M | 0.00 | 62.00K | 0.00 |
| DeferredTax | -684.12K | 0.00 | ||
| DeferredIncomeTax | -684.12K | 0.00 | ||
| DepreciationAmortizationDepletion | 384.17K | 432.60K | 1.36M | 1.29M |
| DepreciationAndAmortization | 384.17K | 432.60K | 1.36M | 1.29M |
| OperatingGainsLosses | -319.63K | -7.40M | -860.48K | -7.41M |
| GainLossOnInvestmentSecurities | -319.63K | -7.40M | -854.40K | -7.41M |
| GainLossOnSaleOfPPE | 0.00 | -6.08K | 0.00 | 208.78K |
| NetIncomeFromContinuingOperations | -14.96M | -6.79M | -10.02M | -8.27M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|